Abstract:The number of mitochondria in the oocyte along with their functions (e.g., energy production, scavenger activity) decline with age progression. Such multifaceted functions support several processes during oocyte maturation, ranging from energy supply to synthesis of the steroid hormones. Hence, it is hardly surprising that their impairment has been reported in both physiological and premature ovarian aging, wherein they are crucial players in the apoptotic processes that arise in aged ovaries. In any form, ovarian aging implies the progressive damage of the mitochondrial structure and activities as regards to ovarian germ and somatic cells. The imbalance in the circulating hormones and peptides (e.g., gonadotropins, estrogens, AMH, activins, and inhibins), active along the pituitary-ovarian axis, represents the biochemical sign of ovarian aging. Despite the progress accomplished in determining the key role of the mitochondria in preserving ovarian follicular number and health, their modulation by the hormonal signalling pathways involved in ovarian aging has been poorly and randomly explored. Yet characterizing this mechanism is pivotal to molecularly define the implication of mitochondrial dysfunction in physiological and premature ovarian aging, respectively. However, it is fairly difficult considering that the pathways associated with ovarian aging might affect mitochondria directly or by altering the activity, stability and localization of proteins controlling mitochondrial dynamics and functions, either unbalancing other cellular mediators, released by the mitochondria, such as non-coding RNAs (ncRNAs). We will focus on the mitochondrial ncRNAs (i.e., mitomiRs and mtlncRNAs), that retranslocate from the mitochondria to the nucleus, as active players in aging and describe their role in the nuclear-mitochondrial crosstalk and its modulation by the pituitary-ovarian hormone dependent pathways. In this review, we will illustrate mitochondria as targets of the signaling pathways dependent on hormones and peptides active along the pituitary/ovarian axis and as transducers, with a particular focus on the molecules retrieved in the mitochondria, mainly ncRNAs. Given their regulatory function in cellular activities we propose them as potential diagnostic markers and/or therapeutic targets.

Cellular senescence in the pathogenesis of ovarian dysfunction

The role of cellular senescence in ovarian aging

The Role of Cellular Senescence in Cyclophosphamide-Induced Primary Ovarian Insufficiency

Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome

Excessive Oxidative Stress in Cumulus Granulosa Cells Induced Cell Senescence Contributes to Endometriosis-Associated Infertility.

Ovarian aging: mechanisms and intervention strategies

Cellular Senescence in the Treatment of Ovarian Cancer

Senescent Cells: A Therapeutic Target for Osteoporosis

Positive and negative effects of cellular senescence during female reproductive aging and pregnancy

Ovarian Aging: Molecular Mechanisms and Medical Management

Cellular senescence in reproduction: a two-edged sword

A comprehensive multi-omics signature of doxorubicin-induced cellular senescence in the postmenopausal human ovary.

[Advances in the study of ovarian dysfunction with aging]

The role of oxidative stress in ovarian aging: a review

Mechanisms of ovarian aging in women: a review

Ovarian Stem Cell Nests in Reproduction and Ovarian Aging.

The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities

Ovarian Aging: Role of Pituitary-Ovarian Axis Hormones and ncRNAs in Regulating Ovarian Mitochondrial Activity

Primary oocytes with cellular senescence features are involved in ovarian aging in mice

Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence